Finacea Foam (azelaic acid) NDC 50222-303

NDC codes

FDA NDC Directory

Product NDC (as listed)50222-303Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50222-0303Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50222-303-50	50222030350	1 CAN in 1 CARTON (50222-303-50) / 50 g in 1 CANMarketed from Oct 1, 2018
50222-303-91	50222030391	1 CAN in 1 CARTON (50222-303-91) / 15 g in 1 CANMarketed from Oct 1, 2018 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Finacea Foam
Generic name (nonproprietary): azelaic acid
Active ingredients: Azelaic acid — .15 g/g
Dosage form: Aerosol, Foam
Route: Topical
Labeler: LEO Pharma Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 207071
Marketing start: Oct 1, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Protein Synthesis (Physiologic effect)Decreased Sebaceous Gland Activity (Physiologic effect)
Identifiers: Product ID 50222-303_f51a0452-513f-488f-b0f9-b723cf96bdf7SPL ID f51a0452-513f-488f-b0f9-b723cf96bdf7SPL set ID 9fabd24e-4c3b-49a0-aa5f-c8d75ae67572RxCUI 1659800, 1659803UNII F2VW3D43YT

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450222030350 followed by a unit qualifier and the quantity

Package 50222-0303-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 8, 2020.

Indications (excerpt from the label)

FINACEA Foam, 15% is indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. FINACEA Foam is indicated for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)